BEOVU (brolucizumab)

**Product type:** Human Prescription Drug

**Active ingredient:** BROLUCIZUMAB

**Strength:** 6 mg/.05mL

**Dosage form:** Injection, Solution

**Route:** Intravitreal

**Labeler:** Novartis Pharmaceuticals Corporation

**Marketing category:** BLA (BLA761125)